ApprovalTrail

Approval · Notice of Compliance 5116 · 1995

ALOMIDE: Notice of Compliance 5116

Issued March 30, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5116
Date
March 30, 1995
Company
Alcon Canada Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Revised product monograph
Therapeutic class
Anti-allergy agent

Products in this notice

BrandDINStatus today
ALOMIDENot yet assigned—

Medicinal ingredients